uniQure N.V. Soared
Tue, Jul 09, 2024 at 07:20 PM
uniQure N.V. (QURE:NASDAQ) shot up at $6.67, representing a gain of 76.5%. On Tue, Jul 09, 2024, QURE:NASDAQ hit a New 2-Week High of $6.67. The stock got featured on our News Catalysts scanner on Tue, Jul 09, 2024 at 08:22 AM in the 'BIOTECH' category. From Tue, Jun 25, 2024, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Wed, Feb 28, 2024 at $6.87 with a volume of 1M+.
About uniQure N.V. (QURE:NASDAQ)
uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.
Top 10 Gainers:
- Soligenix, Inc. (SNGX:NASDAQ), 271%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 94.26%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 91.67%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 84.18%
- uniQure N.V. (QURE:NASDAQ), 76.46%
- Naas Technology Inc. (NAAS:NASDAQ), 68.39%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Shineco Inc. (SISI:NASDAQ), 43.17%
- Longeveron Inc. (LGVN:NASDAQ), 38.65%